Find clinical trials for AbbVie. Search for AbbVie clinical trials in different cities and states across the United States.
Filter
Filter results
Results: 91
Featured
A Study to Assess the Safety and Effectiveness of ELAPR002f Injectable Gel in Adult Participants With Atrophic Acne Scars
for
Acne Scars
Location: Westport CT, Mount Kisco NY, Baltimore MD,
Sponsor: AbbVie
Sex: All
Age: 22+
Code: NCT07207369
Phase 3, Recruiting
Featured
Study of AGN-151607-DP to Assess Adverse Events and Change in Disease Activity in Adult Participants With Upper Limb Essential Tremor
for
Upper Limb Essential Tremor
Location: Boca Raton FL, Orlando FL, Fresno CA
Sponsor: AbbVie
Sex: All
Age: 18 - 70+
Code: NCT07673107
Phase 2, Recruiting
Featured
A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Single Ascending Doses of ABBV-1451 Infusions and Injections in Healthy Adult Participants
for
Healthy Volunteer
Location: Grayslake IL
Sponsor: AbbVie
Sex: All
Age: 18 - 60
Code: NCT07570147
Phase 1, Recruiting
Featured
A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions of ABBV-319 in Adult Participants With Systemic Lupus Erythematosus (SLE), Sjogren's Disease (SjD) and Rheumatoid Arthritis (RA)
for
Dry Eye Syndrome, Systemic Lupus Erythematosus
Location: Margate FL, Tampa FL, Orland Park IL, Memphis TN,
Sponsor: AbbVie
Sex: All
Age: 18 - 70+
Code: NCT06977724
Phase 1, Recruiting
Featured
Study to Assess the Adverse Events and How Intravitreal ABBV-6628 Moves Through the Body of Adult Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Location: Carmel IN, The Woodlands TX, Dallas TX, Abilene TX,
Sponsor: AbbVie
Sex: All
Age: 50+
Code: NCT07160179
Phase 1, Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Featured
Study of Intravenously (IV) Infused Etentamig in Combination With an Oral Cereblon E3 Ligase Modulatory Drug (CELMoD) Agent Assessing Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma
for
Multiple Myeloma
Location: New York NY, New Brunswick NJ, Montreal,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT06896916
Phase 1, Recruiting
Featured
A Study to Assess Adverse Events and Change in Disease Activity in Participants With Platinum-Resistant Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression Treated With Intravenously (IV) Infused Mirvetuximab Soravtansine
for
Advanced High-Grade Epithelial Ovarian Cancer,
Location: Worcester MA, Pittsburgh PA, Sarasota FL, Detroit MI,
Sponsor: AbbVie
Sex: Female
Age: 18+
Code: NCT06682988
Phase 2, Recruiting
Featured
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations
for
Multiple Myeloma
Location: New York NY, Chapel Hill NC, Winston-Salem NC,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT06892522
Phase 1, Phase 2, Recruiting
Featured
Study of Targeted Therapies for the Treatment of Adult Participants With Active Psoriatic Arthritis
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Immunoglobulin Light Chain (AL) Amyloidosis Receiving Etentamig (ABBV-383) as an Intravenous (IV) Infusion
for
Immunoglobulin Light Chain (AL) Amyloidosis
Location: Boston MA, New York NY, Miami FL, Winston-Salem NC,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT06158854
Phase 1, Phase 2, Recruiting
Featured
Evaluation of the Safety and Effectiveness of ARTIA Reconstructive Tissue Matrix Breast Reconstruction (ADORA) in Adult Participants